Treatment options for C3 glomerulopathy

Overview of attention for article published in Current opinion in nephrology and hypertension, March 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter: 5 X users

patent: 4 patents

Readers on

mendeley: 53 Mendeley

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 19,018 followers.

Optimal treatment for C3 glomerulonephritis has not been established. Some patients with C3 glomerulonephritis respond to myophenolate and/or eculizumab. Patients with CFH mutation respond to plasma exchange. #DiseaseWeek https://t.co/sXCziy26ig

RT @arkanalabs: Some patients with C3 glomerulonephritis respond to mycophenolate and/or eculizumab. Patients with CFH mutation respond to…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 2 additional X posts.